Apothca, Inc. Set to Open the First Medical Marijuana Dispensary in Arlington, Massachusetts

Thursday, October 25, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Apothca launches the first of its three Registered Marijuana Dispensaries in Massachusetts in Arlington

ARLINGTON, Mass., Oct. 24, 2018 /PRNewswire-PRWeb/ -- Apothca, Inc. is set to open its first Registered Marijuana Dispensary

("RMD") at 11 Water Street, Suite 3B, Arlington, Massachusetts 02476 on Friday October 26, 2018.

This will be Apthoca's first medical marijuana dispensary in Massachusetts and the first in Arlington.

"Apothca is excited at the opportunity to serve the medical cannabis needs of the patients of Arlington and surrounding communities. As Arlington's only Registered Marijuana Dispensary, we understand the gravity of our mission and our team of cultivators, extractors and patient advocates are ready to take on the challenge," said Daniel Karten, co-founder of Apothca, Inc.

Apothca is a vertically integrated cannabis operation with a 26-acre cultivation campus in Fitchburg, MA, which includes first greenhouse in the Commonwealth of Massachusetts.

Patients visiting Apothca locations will have access to an assortment of medical cannabis products and accessories including flower, concentrates, pre-rolled joints, edibles, tinctures, and full spectrum CBD products.

Apothca will open its second store in the coming weeks at 491 Lynnway, Lynn, MA and anticipates a third store in Boston in early 2019.

All new patients that visit an Apothca location in Massachusetts will be eligible to received $20 off their purchase of $100 or more on their first two visits. Additionally, Apothca will offer all patients half-gram pre-rolls for $8.

Apothca also operates a recreational marijuana dispensary in Eugene, Oregon and is launching cultivation, extraction, research and export operations in Colombia.

Please visit us at apothca.com for more information.

For all inquiries, please email info@apothca.com.

 

SOURCE Apothca, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store